Request an appointmentat Mayo Clinic
Dr. Mohamed Kharfan Dabaja discusses who is eligible for CAR-T cell therapy, the treatment process and its potential side effects.
After receiving CAR-T cell therapy for chronic lymphocytic leukemia through a clinical trial at Mayo Clinic, Jon Stahlecker is cancer free and feeling good.
Researchers used a new immunotherapy technique that combines chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, with a cancer-killing virus to more effectively target and treat solid cancer tumors in mouse models.
Learn about CAR-T cell therapy, a personalized treatment giving hope to patients diagnosed with various lymphomas.